Euclidean Capital LLC Alector, Inc. Transaction History
Euclidean Capital LLC
- $265 Million
- Q1 2025
A detailed history of Euclidean Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 1,307,858 shares of ALEC stock, worth $2.18 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
1,307,858
Previous 1,307,858
-0.0%
Holding current value
$2.18 Million
Previous $2.47 Million
34.93%
% of portfolio
0.61%
Previous 0.34%
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
147Shares Held
55.5MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$16.2 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$15.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$10.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$3.28 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$2.74 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $138M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...